Skip to main content
Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).
Published Web Locationhttps://doi.org/10.1111/j.1475-6773.2009.01039.x
ObjectiveTo assess HIV vaccine acceptability among high-risk adults in Los Angeles.
Study settingSexually transmitted disease clinics, needle/syringe exchange programs, Latino community health/HIV prevention programs.
Study designCross-sectional survey using conjoint analysis. Participants were randomly selected using three-stage probability sampling.
Data collectionSixty-minute structured interviews. Participants rated acceptability of eight hypothetical vaccines, each with seven dichotomous attributes, and reported post-vaccination risk behavior intentions.
Principal findingsParticipants (n=1164; 55.7 percent male, 82.4 percent ethnic minority, mean age=37.4 years) rated HIV vaccine acceptability from 28.4 to 88.6; mean=54.5 (SD=18.8; 100-point scale). Efficacy had the greatest impact on acceptability, followed by side effects and out-of-pocket cost. Ten percent would decrease condom use after vaccination.
ConclusionsFindings support development of social marketing interventions to increase acceptability of "partial efficacy" vaccines, behavioral interventions to mitigate risk compensation, and targeted cost subsidies.
For improved accessibility of PDF content, download the file to your device.